Name/
Symbol
|
Strain Name
|
Transgene/
Promoter and Regulatory Elements
|
Genetic Background
|
Behavioral
Phenotype
|
Neurological
Characteristics
|
Patents/
Availability
|
Primary Citation
|
|
Tg(tetO-MAPT*P301L)#Kha/
Symbol: Tau
(rTg4510 mice; also called rTg(tauP301L)4510)
Posted 02/14/12
|
FVB-Tg(tetO-MAPT*P301L)#Kha/J
|
P301L mutation in human 4-repeat tau. Tetracycline operator (tetO) upstream of a
cytomegalovirus minimal promoter.
|
Background: FVB/N.
|
N/A
|
These mice were found to express about 13 units of P301L tau (one unit is equivalent
to the level of endogenous murine tau).
|
The Jackson Lab.
Under Development. Accepting orders for estimated distribution in March 2012. Stock
Number: 015815. Use by companies or for-profit entities requires a license prior
to shipping.
|
SantaCruz et al., 2005
|
|
ΔTau74
Symbol: Tau
Posted 08/03/10
|
|
aa256-411 removed from htau 40/mouse Thy1.2 promotor.
|
Origin: B6D2F1×B6D2F1; Background C57BL/6.
|
N/A
|
Line 74 expresses transgene 1.4x endogenous tau. Bigenic mice (crossed with Tau P301L) disrupts postsynaptic targeting of Fyn, uncouples
NR-mediated excitotoxicity and hence mitigates Aβ toxicity.
|
Contact: Jürgen Götz (juergen.goetz@sydney.edu.au)
and Lars Ittner (lars.ittner@sydney.edu.au).
|
Ittner et al., 2010
|
|
(Tau K369I) K3
Symbol: Tau
Posted 07/29/10
|
|
Human K369I tau, lacking exon3, containing four MT-binding domains/ murine Thy 1.2.
|
Origin: B6D2F1xB6D2F1; Backcross: 10-fold; Background: C57BL/6.
|
Early-onset (four weeks) motor phenotype of parkinsonism with tremor, bradykinesia,
abnormal gait, and postural instability.
|
Early-onset memory impairment and FTD-assoc. Parkinson. K369I expressed in cortex,
hippocampus, basal ganglia and substantia nigra. L-dopa partially reverses symptoms.
|
Contact: Jürgen Götz (juergen.goetz@sydney.edu.au)
and Lars Ittner (lars.ittner@sydney.edu.au).
|
Ittner et al., 2008
|
|
TTBK1 (line141)
Symbol: Tau
Posted 06/27/10
|
|
OE huTau-tubulin kinase 1/endogenous huTTBK1 promoter.
|
Origin: B6/SjL; Backcross: B6/129 for >5 generations; Current generation: >10.
|
Significant age-dependent memory impairment in radial arm water maze.
|
Enhanced CDK5/p35/p25 activity and NMDA receptor downregulation.
|
For licensing, please contact the following licensing agency: UNeMed Corporation,
(402) 559-2468, www.unemed.com
|
Sato et al., 2008
|
|
MCH-GFP
Symbol: Tau
Posted 3/16/09
|
B6.Cg-Tg(Pmch-MAPT/GFP*)1Rck/J
|
BAC vector carrying Tau (MAPT)-Topaz GFP in exon 1/Pmch, pro-melanin-concentrating
hormone promoter/ B6CBAF1 embryos.
|
Origin: (C57BL/6 x CBA)F1; Generation: N10+ (22-Dec-08); Backcross: C57BL/6.
|
Hemizygotes are viable and fertile and do not display any gross physical or behavioral
abnormalities.
|
Neurons expressing PMCH can be easily identified in the brain.
|
The Jackson Lab,
available, Stock # 008324. Use by companies or for-profit entities requires a license
prior to shipping.
|
|
|
MC4R-GFP
Symbol: Tau
Posted 3/16/09
|
B6.Cg-Tg(Mc4r-MAPT/GFP*)1Rck/J
|
BAC vector carrying Tau (MAPT)-Sapphire GFP in ATG site in mouse melanocortin 4
receptor (Mc4r) gene/B6CBAF1 embryos/Line 21.
|
Origin: (C57BL/6 x CBA)F1; Generation: N11+F1 (15-Jan-09); Backcross: C57BL/6.
|
Hemizygotes are viable and fertile and do not display any gross physical or behavioral
abnormalities.
|
GFP expression is detected in numerous brain regions and is identical to that of
melanocortin-4 mRNA.
|
The Jackson Lab,
available, Stock # 008323. Use by companies or for-profit entities requires a license
prior to shipping.
|
Liu et al., 2003
|
|
Pomc-GFP
Symbol: Tau
Posted 3/16/09
|
B6.Cg-Tg(Pomc-MAPT/GFP*)1Rck/J
|
BAC vector carrying Tau (MAPT)-Sapphire GFP/ mouse pro-opiomelanocortin-alpha (Pomc)
promoter/B6CBAF1 embryos.
|
Origin: (C57BL/6 x CBA)F1; Generation: N11+N1 (18-Dec-08); Backcross: C57BL/6.
|
Hemizygotes are viable and fertile and do not display any gross physical or behavioral
abnormalities.
|
GFP in POMC expressing cells is expressed in neurons in the hypothalamic arcuate
nucleus.
|
The Jackson Lab,
available, Stock # 008322. Use by companies or for-profit entities requires a license
prior to shipping.
|
Pinto et al., 2004
|
|
NPY-GFP
Symbol: Tau
Posted 3/16/09
|
B6.Cg-Tg(Npy-MAPT/GFP*)1Rck/J
|
BAC vector carrying Tau (MAPT)-Sapphire GFP/ mouse neuropeptide Y (Npy) promoter/B6CBAF1
embryos.
|
Origin: (C57BL/6 x CBA)F1; Generation: N11+N1F1 (18-Dec-08); Backcross: C57BL/6.
|
Hemizygotes are viable and fertile and do not display any gross physical or behavioral
abnormalities.
|
Fluorescence is observed in distinct neuronal populations of the hypothalamic arcuate
nucleus.
|
The Jackson Lab,
available, Stock # 008321. Use by companies or for-profit entities requires a license
prior to shipping.
|
Pinto et al., 2004
|
|
P301S tau (line PS19)
Symbol: Tau
Posted 1/16/09
|
B6;C3-Tg(Prnp-MAPT*P301S)PS19Vle/J
|
HuP301S mutation MAPT/Mo Prnp promoter/injected into fertilized B6C3F1 eggs/bred
to B6C3F1/J or B6C3F1/Crl mice.
|
Origin: (C57BL/6 x C3H)F1; Background: hemizygotes on B6C3F1; Generation: ?+N1F0
(28-Jul-08).
|
Median lifespan of ~9 months with ~80% dying by 12 months.
|
No plaques, tangles in cortex and hippocampus at 5 months, synaptic loss, neuronal
loss in hippocampus by 8 to 9 months.
|
The Jackson Lab,
available, stock #008169. Use of mice by companies or for-profit entities required
a license prior to shipping.
|
Yoshiyama et al., 2007
|
|
Thy-Tau22
Symbol: Tau
Posted 02/22/07
|
|
Human tau 1N2R with tau mutations G272V and P301S/ Thy 1.2 promotor.
|
Origin: C57Bl/6
|
No motor deficit until more than 2 years.
|
Memory deficits; neurofibrillary tangles, PHF, and ptau (MC1, AT100, pS422, 12E8,
PHF/AD2, AT8, AT180, AT270. Pathology starting in hippocampus.
|
Contact Luc Buee; available for academic
research but not for private companies.
|
Schindowski et al., 2006
|
|
rTg(tauP301L) 4510
Symbol: Tau
Posted 12/10/05
|
|
Mice expressing activator transgenes tet-off ORF downsteam of Ca2+ calmodulin kinase
II promoter/Mice expressing responder transgene, TRE upstream of 4R0N tauP301L mutation.
|
Origin: Activator transgene mice on 129S6, backcross 5x. Responder transgene mice
(Tau P301L) on FVB/N.
|
Spatial defects, cognitive impairments early. At 9.5 months exhibit decreased ambulation,
body wt, hunched posture but continue to live, now >20 months.
|
Progressive age-related NFTs, and neuronal loss and severe forebrain atrophy. Tau
mRNA restricted to forebrain (neuronal cell types). With doxycycline treatment,
memory function recovered, neuron numbers stabilized, but NFTs continued to accumulate.
|
Contact Dr. Susan Stoddard
Mayo Medical Ventures, Rochester, MN
|
SantaCruz et al., 2005
|
|
Tau4R-P301L
Symbol: Tau
Posted 6/10/05
|
|
Human Tau-P301L in the Tau-4R/2N isoform/ mouse Thy 1 promoter/injected pronuclear
FVB/N embryos
|
Origin: FVB/N
|
Clasping, impaired; Rotarod, normal; Beam walk, failed >9 months; Mean life span,
<12 months.
|
Expression level, similar to Tau-4R/2N; Axonal dilations, absent; Intra-neuronal
tau aggregates (NFT) , progressive > 6 months, severe at 9-12 months
|
Contact Paul Vandun
|
Terwel et al., 2005
|
|
Tau-4R-KOKI
Symbol: Tau
Posted 6/10/05
|
|
Human Tau-4R/2N with no mouse endogenous tau/mouse Thy1 promoter/electroporation
ES cells
|
Origin: FVB/N Backcrossed N8
|
Rotarod, slight impairment > 6 months; Clasping, normal; Beam, slight impairment
> 6 months; Mean life span: normal
|
Expression level, similar to endogenous mouse tau with all isoforms combined. Axonal
dilations, absent. Tau aggregates, absent.
|
Contact Paul Vandun
|
Terwel et al., 2005
|
|
Tau R406W
Symbol: Tau
Posted 3/6/05
|
|
Longest human Tau/R406W mutation/MoPrP.Xho/model of human FTDP-17
|
Origin B6C3, Line 37 maintained as homozygous
|
Hind leg weaknesses in older mice
|
Mutation promotes the formation of tau lesions with advancing age in neuronal perikarya
by novel mechanism initiated by induced impairment of MT binding. This leads to
retardation in the slow axonal transport of tau, followed by a cascade of events
that culminate in the fibrillization of tau and the formation of NFTs.
|
Contact Virginia M.-Y.Lee
|
Zhang et al., 2004
|
|
Human wt Tau
Symbol: Tau
Posted 3/6/05
|
|
human WT tau mutation /MoPrP.Xho/maintain as homozygous
|
Origin: B6C3; Lines 1 and 23 studied
|
90% survive to 24 months
|
hTau expression is 8-10 times higher than endogenous tau in line 23. No age-dependent
accumulation of tau aggregates, no neurodegeneration.
|
Contact Virginia M.-Y.Lee
|
Zhang et al., 2004
|
|
Tau Tα1-3RT
Symbol: Tau
Posted 3/3/05
|
|
Minigene of h3RT in pKS vector embedded into modified exons 1-4 in shortest Tau
cDNA/ mouse tubulin Tα1 promoter cloned into pcDNA3 vector/ SalI/PvuII fragment
of minigene ligated into Tα-1 promoter vector to make Tα1-3RT construct.
|
B6SJL, maintain as heterozygous
|
Mice developed progressive motor weakness in hind and forelimbs. By 24 months of
age, limb twitch was observed in 72% of tg mice, compared with 18% of wt mice.
|
Progressive accumulations of tau in astrocytes and oligodendrocytes associated with
degeneration of these cells and disruption of myelin sheaths. Aged mice showed numerous
glial tau inclusions that were similar to the glial tau pathologies in FTDs.
|
Contact Virginia M.-Y.Lee
|
Higuchi et al., 2002
|
|
Tauvlw
Symbol: Tau
Updated 1/25/06
|
|
Linked mutations G272V, P301L, and R406W/site directed mutagenesis hCNS tau cDNA/Mouse
Thy-1 promoter with deleted lymphoid enhancer.
|
Origin C57Bl6J x CBA, Backcross to C57Bl/6J 10 generations.
|
|
Mice overexpress human mutant Tau in cortex and hippocampus, minimally in spinal
cord. Pretangle appearance in neurons expressing mutant tau with filaments of tau
and lysosomes having aberrant morphology.
|
Contact J. Avila
javila@cbm.uam.es
|
Lim et al., 2001
|
MAPT Mapt EGFP
(See JAX datasheet)
Updated 1/16/09
|
STOCK Mapttm1(EGFP)Klt Tg(MAPT)8cPdav/J
|
Double mutant mice were generated by crossing hTau transgenic mice (mouse line 8C) with Mapt targeted mutant
mice (Mapt exon disrupted, replaced with EGFP fused to the first 31 MAPT aa; see
Stock # 004779.
|
Targeted allele = J1 ES cell then C57BL/6 blastocysts, homozygous. Transgenic allele=
Swiss Webster/ B6D2F1, hemizygous; Gen F8 (01-Dec-06)
|
Mice are viable and fertile.
|
No endogenous mouse Tau, six isoforms of hTau expressed. Hyperphosphorylated tau
detected in cell bodies and dendrites. Paired helical filaments of aggregated insoluble
Tau isolated from brain at 2 months.
|
Cryopreserved
The Jackson Lab:
Stock #004808
Use of mice by companies or for-profit entities required a license prior to shipping.
|
Andorfer et al., 2003
|
MAPT Mapt EGFP
(See JAX datasheet)
Updated 1/16/09
|
B6.CgMapttm1(EGFP)Klt Tg(MAPT)8cPdav/J
|
Crossed transgenic mice (mouse line 8C) with Mapt. Targeted mutant mice #004779.
|
Generation N9+1F7 (31-Dec-08).
|
Homozygous for the targeted allele and hemizygous for the transgene. Viable and
fertile.
|
No endogenous mouse Tau, six isoforms of hTau expressed. Hyperphosphorylated tau
detected in cell bodies and dendrites. Paired helical filaments of aggregated insoluble
Tau isolated from brain at 2 months.
|
Available
The Jackson Lab:
Stock #005491
Use of mice by companies or for-profit entities required a license prior to shipping
|
Andorfer et al., 2003
|
Mapt EGFP
(See Jax Datasheet)
Symbol: EGFP
Updated 1/16/09
|
STOCK Mapttm1(EGFP)Klt/J
|
cDNA for the enhanced green fluorescent protein (EGFP) was inserted into exon one
of tau Mtapt/J1 EScells/C57Bl/6
|
Origin: mixed background of C57BL/6 and 129/SvJae. Generation: N1F7 (08-Jan-08).
|
Viable, fertile, normal in size and do not display any gross physical or behavioral
abnormalities.
|
No gross abnormalities in central or peripheral nervous system. GFP seen in neuronal
cell bodies and cranial ganglia persists throughout life.
|
Available
The Jackson Lab #004779
|
Tucker et al., 2001
|
|
Tau ko
Symbol: Tau
Updated 1/16/09
|
B6.129-Mapttm1Hnd/J
|
Replaced exon 1 of mouse tau gene with neo resistant cassette/endogenous promoter.
|
Origin: C57BL/6 x 129SvJ hybrids. Backcross C57BL/6. Generation: N9+F2 (08-Jan-08).
|
Homozygous mice are viable, fertile, normal in size, and do not display any gross
physical or behavioral abnormalities.
|
No expression of Tau protein. Embryonic hippocampal cultures show delay in maturation
and are resistant to AB treatment. Human tau proteins can rescue tau-deficient mouse
neurons.
|
The Jackson Lab,
available, stock # 007251. For research or non-commercial use only.
|
Dawson et al., 2001
|
|
T-N279K
Symbol: Tau
Posted 12/19/04
|
|
Minigene of hCNS exons and intronic sequences surrounding exons 2, 3 and 10/ N279K
mutation/hTau promoter.
|
C57BL/6 x SJL hybrids
|
Cognitive impairment on radial arm water maze at 52 weeks. Some mice develop motor
deficits leading to hind limb paralysis and early demise.
|
Numerous abnormal tau and phospho-tau reactive neurons and glia. Expression of hTau
at same level as endogenous. Mice exhibit pathology similar to patients with mutation
ie.tau positive tufted astrocytes.
|
Contact Hana Dawson
dawso009@mc.duke.edu
|
Unpublished
|
|
T-WT
Symbol: Tau
Posted 12/19/04
|
|
Minigene of the human CNS expressed exons and intronic sequences surrounding exons
2, 3 and 10/Human Tau promoter
|
C57BL/6 x SJL hybrids
|
Breed normally. Normal behavior
|
No neuropathology. Molecularly, tau isoforms with and without exon 10 are expressed
at a 1:1 ratio. Protein expression is ~ 3 times the level of endogenous mouse tau
protein.
|
Contact Hana Dawson
dawso009@mc.duke.edu
|
Unpublished
|
|
human Tau
Symbol: Tau
Posted 12/18/04
|
|
PAC 24i13 containing the entire human TAU gene (~200 kBp)/human tau promoter.
|
Origin:C57BL/6 x SJL hybrids. Backcross C57BL/6 Gen N8
|
Hemizygous mice breed normally; homozygous mice have low level of pregnancies and
smaller litters.
|
Increased immunoreactivity to most tau antibodies with some somatodendritic relocalization.
No tau aggregates.
|
Contact Hana Dawson
dawso009@mc.duke.edu
|
Dawson et al., 2001
|
|
C-N279K
Symbol: Tau
Posted 12/18/04
|
|
Minigene of hCNS exons and intronic sequences surrounding exons 2, 3 and 10/ N279K
mutation/CMV promoter
|
Origin: C57BL/6 x SJL hybrids
|
Normal.
|
Molecularly, tau isoforms are expressed almost exclusively with exon 10 in adult
mice as seen in patients with the mutation.
|
Contact Hana Dawson
dawso009@mc.duke.edu
|
Unpublished
|
Tau P301L-JNPL3
(See Taconic datasheet)
Symbol:Tau
Updated 11/1/10
|
STOCK Tg(Prnp-MAPT*P301L)JNPL3Hlmc
|
Tau P301L/mouse prion promoter/microinjected C57BL/6 x DBA2 X SW fertilized eggs.
|
SW/B6D2F1, line maintained by mating of homozygous mice.
|
Behavioral and motor disturbances related to development of NFT.
|
Phenotype mimics human tauopathies in a more rapid timeframe than the hemizygous
model.
|
Taconic
Available: Stock #002508-M (homozygous). For research purposes only. For breeding
must have a Research Crossbreeding Agreement with Taconic. No distribution to third
parties.
|
Lewis et al.
|
Tau P301L-JNPL3
(See Taconic datasheet)
Symbol:Tau P301L
Updated 11/1/10
|
STOCK Tg(Prnp-MAPT*P301L)JNPL3Hlmc
|
Longest human Tau isoform with 4 repeats containing exon 10 and lacking exons 2
and 3 with P301L/
mouse prion promoter (MoPrP)
|
C57BL/DBA2/SW
|
Severe motor and behavioral disturbances
observed early
|
hTau level equal to endogenous tau in hemizygous mice, but 2x the level in homozygous
mice. NFT and neuronal loss in brain and spinal cord
|
Unpatented
Taconic
Available
001638T (hemizygous)
001638W (wildtype). For research purposes only. For breeding must have a Research
Crossbreeding Agreement with Taconic. No distribution to third parties.
|
Lewis et al.
|
|
Tau P301L
Line: pR5-182
Updated 3/3/04
|
|
Human tau40 isoform with 4 repeats, exons 2 and 3 with P301L/
neuron-specific mouse Thy1.2 promoter.
|
STOCK (mixed C57BL/6, DBA/2, SW).
|
Signs of Wallerian degeneration, neurogenic muscle atrophy, muscle weakness.
|
Numerous abnormal, tau-reactive nerve cell bodies and dendrites; large numbers of
pathologically enlarged axons containing neurofilament and tau-reactive spheroids.
Neuronal lesions similar to FTDP-17.
|
Unpatented
Contact Jurgen Gotz
goetz@bli.unizh.ch
|
Gotz J et al
|
|
Tau R406W
Updated 11/4/03
|
|
Human longest tau cDNA with R406W mutation containing myc and FLAG tags at N- and
C- terminal ends, respectively/αCaMk-II promoter
|
B6SJL/F1 backcrossing with C57BL/6J
|
Impaired associative memory in contextual and cued fear conditioning test. Abnormality
in prepulse inhibition and forced swim test. No overt sensorimotor deficit.
|
Accumulation of insoluble tau in aged mice. Congophilic hyperphosphorylated tau
inclusions only in forebrain neurons of aged mice.
|
Unpatented
Contact: Akihiko Takashima
|
Tatebayashi et al.
|
|
Tau G272V
|
|
Human tau40 with G272V mutation/ murine prion protein promoter
|
B6D2F1 x B6D2F1 founder mice inter-crossed with C57BL/6 mice
|
No neurological deficits readily noticeable
|
Filaments in murine oligodendrocytes, associated with tau phosphorylation at AT8
epitope 202/205 in vivo. In the spinal cord, fibrillary inclusions identified by
thioflavin-S in oligodendrocytes and motor neurons
|
Unpatented
Contact Jurgen Gotz
goetz@bli.unizh.ch
|
Gotz J et al
|
|
Tau V337M
Updated 11/4/03
|
|
Human longest tau cDNA with V337M mutation/PDGF-b promoter,
neuron-specific mouse Thy1.2 promoter
|
B6SJL background
|
Higher overall spontaneous locomotion. No significant difference in a Morris water
maze test. Significant difference in elevated plus maze test and conditional fear
test.
|
Neurons of irregular shape in hippocampus were immunoreactive for paired helical
filament-associated tau, and showed signs of atrophic cell death disappeared microtubules.
|
Patented
Contact Akihiko Takashima
|
Tanemura et al.
|
T44 (3 repeats)
Symbol: MAPT
Updated 1/16/09
|
B6D2-Tg(Prnp-MAPT)43Vle/J
|
Shortest human Tau isoform with 3 repeats, wildtype/
Murine Prion Protein, MoPrP.Xho expression vector at XhoI site.
|
B6D2/F1. Generation: N5+N1p (19-Feb-06).
|
Progressive motor weakness,
impaired ability to stand on a slanted surface.
|
Accumulation of insoluble tau, profound astrocytosis and axonal degeneration.
|
Cryopreserved. (See
Jax Datasheet stock #003741).
|
Ishihara et al., 1999
|
|
Tau4R/2N
Updated 1/27/05
|
|
Longest human Tau isoform with 4 repeats, wildtype/mouse thy-1 cassette, The thymus
specific regulatory elements in intron 3 are thereby deleted, making the resulting
promoter "neuron-specific"
|
FVB/N
|
Unable to spread hindlimbs when lifted by the tail. Motor disturbances.
|
Axonal degeneration in brain and spinal cord, astrogliosis and ubiquitination in
accumulated proteins of dilated axons.
|
Unpatented
Contact Paul Vandun
|
Spittaels K et al
|
|
Tau 4-Repeats-Alz17
Updated 1/28/05
|
|
Longest human Tau isoform with 4 repeats, wildtype/mouse Thy.1.2 promoter
|
B6D2F1 x B6D2F1, founder animals were intercrossed with C57BL/6 mice to establish
lines
|
Unable to spread hindlimbs when lifted by the tail. Significant defect in
motor coordination.
|
Prominent somatodendritic staining for hyperphosphorylated tau, and pominent axonopathy
|
Unpatented
Contact M. Goedert
|
Probst
A et al
|
|
PP2A Cα mutant L199P
Symbol: PP2A
Line: Dom1
Updated 3/3/04
|
|
cDNA of the human PP2A Ca mutant L199P was isolated from yeast plasmid YEpDE2.5.12
that carries HAPP2ACa-2512 mutant allele/neuron-specific murine Thy1.2 expression
vector. Normal size and fertility.
|
Pronuclear microinjection of B6D2F1 x B6D2F1 embryos. Founder animals were intercrossed
with C57BL/6 mice to establish lines.
|
N/A
|
High levels of Cα L199P in cortical, hippocampal, and cerebellar neurons. Reduced
PP2A activity in brain. Hyperphosphorylation of endogenous tau protein; tau aggregates
in cortical pyramidal cells and cerebellar Purkinje cells and co-localized with
ubiquitin.
|
Contact Jurgen Gotz
|
Kins, et al., 2001
|
|
PP2A Cα mutant L309A
Symbol: PP2A
Line: DOM5
Posted 8/3/10
|
|
L309A mutant of hu PP2A C/mouse Thy1.2 promoter/expresses dominant negative mutant
form.
|
Origin: B6D2F1×B6D2F1; Background: C57BL/6.
|
Normal size, fertility. No behavior problems or motor function on rotarod. Delayed
postnatal development and hypoplasia of Harderian gland.
|
Transgene expression in hippocampus and cortex. Bigenic mice (crossed with P301L (pR5)). Mice show 7x increase of neurons that phos S422
epitope of tau; 8x increase of tangles than pR5 mice.
|
Contact Jürgen Götz (juergen.goetz@sydney.edu.au)
and Lars Ittner (lars.ittner@sydney.edu.au).
|
Schild et al., 2006
|